Join us in Bethesda
This year, the Drug Discovery and Development for Pulmonary Hypertension Symposium is being co-sponsored by the FDA and brings leading scientists in the fields of pulmonary vascular disease, right heart failure, and clinical trial designs together with the pharmaceutical industry and regulatory authorities to help identify the most promising treatments for future development.
We choose quality, over... more quality.
For each meeting, we assemble a faculty with exceptional achievements and expertise, and choose topics in areas that will influence the development of therapies immediately. Each topic will be critically reviewed by an expert panel, and open dialogue will allow your voice to be heard.
Like-minded people, working towards the same goals.
This symposium serves as a unique forum for stakeholders interested in treatment of pulmonary vascular diseases for the sharing of cutting-edge science with the input of international thought leaders. For researchers involved in the treatment of pulmonary hypertension this meeting should stimulate new ideas and approaches. For the pharmaceutical and biotechnology industries that have an interest in pulmonary vascular diseases, right heart failure or orphan diseases, it is a meeting that should not be missed.
Each registree will recieve a private link with the opportunity to recieve discounted room rates and additonal gratuities in an email shortly after registering.
The event will take place on July 11th & July 12th 2016.
Government & Regulatory Registrations
If you are part of government or regulatory institution and would like to attend this event, please email email@example.com and we will be in touch with registration details.